SS
The startup develops a medical device that utilizes a novel hemostatic technology to control bleeding during surgical procedures without relying on blood-derived materials. This approach reduces the risk of contamination and minimizes postoperative hemorrhage, offering a safer alternative to traditional blood products.
Updated 3 months ago
Funding
$770K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a medical device that utilizes a novel hemostatic technology to control bleeding during surgical procedures without relying on blood-derived materials. This approach reduces the risk of contamination and minimizes postoperative hemorrhage, offering a safer alternative to traditional blood products.